Yüklüyor......
Intersecting Guidelines: Administering Erythropoiesis-Stimulating Agents to Chronic Kidney Disease Patients with Cancer
There has been a dramatic sea change in the use of erythropoiesis-stimulating agents (ESAs) for anemic persons with chronic kidney disease (CKD) or cancer patients undergoing chemotherapy. An important area that has not been addressed previously is a CKD patient who also has a malignancy. Clinical g...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3296236/ https://ncbi.nlm.nih.gov/pubmed/19175532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1525-139X.2008.00524.x |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|